Goldman Sachs’s NxStage Medical Inc. NXTM Stock Holding History

Goldman Sachs’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,000	Closed	-$375K	–	7398
2016 Q1	$375K	Sell	25,000 -175,000	-88%	-$2.93M	﹤0.01%	5046
2015 Q4	$4.38M	Buy	200,000 +32,500	+19%	+$606K	﹤0.01%	2949
2015 Q3	$2.64M	Sell	167,500 -54,100	-24%	-$867K	﹤0.01%	3504
2015 Q2	$3.17M	Buy	+221,600	New	+$3.75M	﹤0.01%	3381
2013 Q4	–	Sell	-96,200	Closed	-$1.27M	–	6877
2013 Q3	$1.27M	Sell	96,200 -3,800	-4%	-$49.8K	﹤0.01%	4381
2013 Q2	$1.43M	Buy	+100,000	New	+$1.26M	﹤0.01%	4059

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Goldman Sachs's NXTM Position: Q1 2019 in Review

Goldman Sachs sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 846,876 shares — an estimated $24.2M sold.

Goldman Sachs first reported a position in NXTM in Q2 2013 and held it in 22 quarters. The position peaked at $35.1M in Q3 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

Goldman Sachs reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
Goldman Sachs sold 846,876 NxStage Medical Inc. shares in Q1 2019, an estimated $24.2M.
Goldman Sachs first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 22 quarters.
Goldman Sachs's NxStage Medical Inc. position peaked at $35.1M in Q3 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.